The FDA is considering a significant update to sunscreen regulations in the U.S. that could allow for the use of bemotrizinol, a highly effective UV filter widely used in Europe and Asia. This move comes after years of criticism that the U.S. has lagged behind other parts of the world in sunscreen innovation.
Currently, the U.S. has only 16 approved UV-filtering ingredients, with the last one being approved in 1999. In contrast, Europe has more than 30 approved ingredients, including bemotrizinol, which was approved in 2000 and has been shown to be safe and effective. Sunscreens containing bemotrizinol are known for being lighter weight, longer-lasting, and less greasy than those with other ingredients.
The FDA’s proposal would allow sunscreen products with bemotrizinol to be sold over the counter in the U.S., potentially expanding the options available to consumers and bringing the country more in line with international standards. This move is seen as a positive step towards improving sun protection for Americans and addressing concerns about the outdated regulations governing sunscreen products.
Sunscreen is essential for protecting the skin from harmful UV rays that can cause skin cancer. Different types of sunscreen, such as mineral and chemical, offer varying levels of protection. Bemotrizinol is a broad-spectrum filter that can effectively block both UVA and UVB rays, offering comprehensive protection against the sun’s harmful effects.
By updating sunscreen regulations and allowing for the use of innovative ingredients like bemotrizinol, the FDA is taking a proactive step towards improving sun protection for Americans. This move is expected to benefit consumers by providing access to more effective and advanced sunscreen products that meet international standards for sun protection.
